Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839

被引：1

作者：

Wong, GA ^{[1
]}

Nigen, S ^{[1
]}

Walsh, S ^{[1
]}

Shear, N ^{[1
]}

机构：

[1] Div Dermatol, Toronto, ON, Canada

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期

关键词：

D O I：

10.1016/j.jaad.2003.10.159

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P155

引用

收藏

页码：P39 / P39

页数：1

相关论文

共 2 条

[1] Phase I studies of ZD 1839 in patients with common solid tumors [J].

LoRusso, PM .

SEMINARS IN ONCOLOGY, 2003, 30 (01) :21-29

[2] Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor [J].

van Doorn, R ;

Kirtschig, G ;

Scheffer, E ;

Stoof, TJ ;

Giaccone, G .

BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (03) :598-601